shipment_ID,catalog_ID,Formula,stereochemistry,sample_MW,purity,PO,Salt_Name,Salt_ratio,MW_salt,volume(uL),concentration(mM),plate_ID,well,SMILES,Name,Batch ID,"Amount, mg (left)"
ALP-POS-ecbed2ba-12,Z5600794089,C27H27ClN4O2,Racemic or presumed racemic or meso,474.981,98.98,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_A,ClC=1C=CC=2CN(CC(=O)NCC3CC3)CC4(CCN(C4=O)C=5C=NC=C6C=CC=CC56)C2C1,"2-[6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-(cyclopropylmethyl)acetamide",H3737514,25.2
ALP-POS-ecbed2ba-7,Z5489567290,C26H25ClN4O2,Racemic or presumed racemic or meso,460.955,98.95,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_B,CNC(=O)C1(CC1)N2CC=3C=CC(Cl)=CC3C4(CCN(C4=O)C=5C=NC=C6C=CC=CC56)C2,"1-[6-chloro-1'-(isoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylcyclopropane-1-carboxamide",H3741793,6.8
EDJ-MED-fb79a796-3,Z5600473262,C20H21ClN6O3S,Racemic or presumed racemic or meso,460.937,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_C,ClC=1C=CC=2CN(CC(C(=O)NC3=NN=CN3C4CC4)C2C1)S(=O)(=O)CC5(CC5)C#N,"6-chloro-2-[(1-cyanocyclopropyl)methanesulfonyl]-N-(4-cyclopropyl-4H-1,2,4-triazol-3-yl)-1,2,3,4-tetrahydroisoquinoline-4-carboxamide",H3728911,26.4
MAT-POS-853c0ffa-6,Z5461592527,C26H21Cl2FN4O3S,Racemic or presumed racemic or meso,559.439,96,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_D,FC=1C=C(Cl)C=2C(=CN=CC2C1)N3CCC4(CN(CC=5C=CC(Cl)=CC54)S(=O)(=O)CC6(CC6)C#N)C3=O,"1-({[6-chloro-1'-(5-chloro-7-fluoroisoquinolin-4-yl)-2'-oxo-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]sulfonyl}methyl)cyclopropane-1-carbonitrile",H3743897,18.8
MAT-POS-be048f2c-7,Z5600473272,C28H24ClN5O2,Racemic or presumed racemic or meso,497.975,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_E,ClC=1C=CC=2CN(CC3(CCN(C3=O)C=4C=NC=C5C=CC=CC45)C2C1)C(=O)C6=CC=NN6C7CC7,"6-chloro-2-(1-cyclopropyl-1H-pyrazole-5-carbonyl)-1'-(isoquinolin-4-yl)-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2'-one",H3724880,15.7
MAT-POS-be048f2c-6,Z5600473271,C28H26ClN5O2,Racemic or presumed racemic or meso,499.991,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_F,CC(C)N1N=CC=C1C(=O)N2CC=3C=CC(Cl)=CC3C4(CCN(C4=O)C=5C=NC=C6C=CC=CC56)C2,"6-chloro-1'-(isoquinolin-4-yl)-2-[1-(propan-2-yl)-1H-pyrazole-5-carbonyl]-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2'-one",H3726691,19.1
MIK-UNK-122557fa,Z5550935871,C24H27ClN4O2,Single unknown enantiomer,438.949,96.4,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_G,"CNC(=O)CN1CC=2C=CC(Cl)=CC2[C@]3(CCN(C3=O)C=4C=NC=C5CCCCC45)C1 |o1:14,r|","rel-2-[(4R)-6-chloro-2'-oxo-1'-(5,6,7,8-tetrahydroisoquinolin-4-yl)-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3709664,53.1
MIK-UNK-1619f2e2,Z5550935856,C24H27ClN4O2,Single unknown enantiomer,438.949,100,200415-FTE / COVID-19,,,0,40,20,1178796-Y40-90,03_H,"CNC(=O)CN1CC=2C=CC(Cl)=CC2[C@@]3(CCN(C3=O)C=4C=NC=C5CCCCC45)C1 |o1:14,r|","rel-2-[(4R)-6-chloro-2'-oxo-1'-(5,6,7,8-tetrahydroisoquinolin-4-yl)-2,3-dihydro-1H-spiro[isoquinoline-4,3'-pyrrolidin]-2-yl]-N-methylacetamide",H3722852,15
